AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)

Q: What does CUSIP 00288U106 represent in this 13F holders report?

CUSIP 00288U106 is the security identifier for ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share used to aggregate holder disclosures.

Q: How many institutions held ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share in Q3 2021?

115 institutional investors reported ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share for Q3 2021. Use the holders table for investor-level position and value details.

CUSIP: 00288U106

Q3 2021 13F Holders as of 30 Sep 2021

Security type / class: Equity / Common Shares, no par value per share
Total 13F shares: 98,697,276
Total 13F value: $1,977,505,786
Share change: +8,153,211
Put/Call ratio: 51%
SEC-reported price per share: $20.04
Number of holders: 115
Value change: +$155,909,310
Number of buys: 74
Number of sells: 49
Shares outstanding: 305,667,944

Security key

00288U106

Report period

Q3 2021

Institutions

115

Top holders

ABCL full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2021 Previous quarter: Q2 2021 AbCellera Biologics Inc. SEC filings AbCellera Biologics Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 00288U106

Newer quarter: Q4 2021 Previous quarter: Q2 2021

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Capital World Investors

Disclosed value leader

Capital World Investors

Comparable rows

15/15

Latest evidence

30 Jun 2021

13F Lead comparable stake: 4.4% Showing 1-6 of 15 holder rows.

Quick read

Capital World Investors leads the comparable SEC ownership view at 4.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Capital World Investors's linked filing trail.

Comparable ownership Top 5

Capital World Investors 4.4%

BAKER BROS. ADVISORS LP 3.4%

Allianz Asset Management GmbH 3.2%

SB Management Ltd 3.2%

Capital International Investors 2.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Capital World Investors	13F Company 13F	4.4%	$295,140,000 13,415,437 shares	—	30 Jun 2021
BAKER BROS. ADVISORS LP	13F Company 13F	3.4%	$229,904,000 10,450,180 shares	—	30 Jun 2021
Allianz Asset Management GmbH	13F Company 13F	3.2%	$218,454,000 9,929,704 shares	—	30 Jun 2021
SB Management Ltd	13F Company 13F	3.2%	$215,978,000 9,817,190 shares	—	30 Jun 2021
Capital International Investors	13F Company 13F	2.3%	$151,670,000 6,894,089 shares	—	30 Jun 2021
ORBIMED ADVISORS LLC	13F Company 13F	2%	$136,906,000 6,223,019 shares	—	30 Jun 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

115

98,697,276

Rows available

115

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders

111

Q3 2021 holders

115

Holder diff

Investor	Q2 2021 Shares	Q3 2021 Shares	Share Diff	Share Chg %	Q2 2021 value	Q3 2021 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend